全球核子医学扫描术诊断设备市场规模、份额、趋势及成长分析报告（2026-2034年）

预计核子医学扫描术诊断设备市场将从 2025 年的 39.3 亿美元成长到 2034 年的 69.1 亿美元，2026 年至 2034 年的复合年增长率为 6.48%。

由于医疗技术的进步和医疗需求的不断增长，核子医学扫描术诊断设备市场预计将迎来显着增长，这主要得益于对精准诊断工具的需求。核子医学影像利用放射性物质对器官和组织的功能进行视觉化，正日益成为各种疾病诊断和治疗中不可或缺的一部分。随着全球人口老化和慢性病的盛行率上升，对核子医学扫描术诊断设备的需求预计将持续成长，从而推动市场扩张。

技术创新在提升核子医学扫描术诊断设备的功能方面发挥着至关重要的作用。正子断层扫描（PET）和单光子发射断层扫描（SPECT）等影像技术的进步提高了诊断影像的准确性和解析度。这些进步使医疗专业人员能够更早发现疾病，从而改善患者的治疗效果。此外，人工智慧（AI）和机器学习在核子医学扫描术诊断中的应用简化了影像分析和解读流程，进一步提高了诊断效率。随着这些技术的不断发展，核子医学扫描术诊断设备市场有望吸引医疗机构和製造商的大量投资。

此外，对个人化医疗和标靶治疗日益增长的关注也推动了核子医学扫描术诊断设备市场的成长。随着医疗保健转向更个人化的治疗方案，对精准诊断工具的需求变得愈发重要。核子医学扫描术诊断设备能够提供关于患者俱体病情的宝贵信息，并有助于制定个人化的治疗方案。此外，对早期检测和预防医学的日益重视也促进了核医学影像技术的应用。随着市场的不断发展，核医学影像与其他诊断方法的融合有望创造新的机会，并进一步加速这个充满活力的领域的成长。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

第四章 全球核子医学扫描术诊断设备市场：依产品类型划分

• 市场分析、洞察与预测
• PET设备
• SPECT设备
• 平面成像设备

第五章 全球核子医学扫描术诊断设备市场：依应用领域划分

• 市场分析、洞察与预测
• 肿瘤学
• 心臟病学
• 神经病学
• 其他领域（肾臟科、免疫学等）

第六章 全球核子医学扫描术诊断设备市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 影像中心
• 学术研究机构
• 其他（诊所、合约研究组织等）

第七章 全球核子医学扫描术诊断设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc
  • Siemens Healthineers AG
  • Canon Medical Systems Corporation
  • Shimadzu Corporation
  • United Imaging Healthcare Co
  • MR Solutions
  • Cubresa Inc
  • Neusoft Medical Systems Co. Ltd
  • Mediso Ltd
  • MIE GmbH
  • Others

The Nuclear Imaging Devices Market size is expected to reach USD 6.91 Billion in 2034 from USD 3.93 Billion (2025) growing at a CAGR of 6.48% during 2026-2034.

The Nuclear Imaging Devices Market is anticipated to witness significant growth as advancements in medical technology and increasing healthcare demands drive the need for accurate diagnostic tools. Nuclear imaging, which utilizes radioactive materials to visualize the functioning of organs and tissues, is becoming an essential component in the diagnosis and management of various medical conditions. As the global population ages and the prevalence of chronic diseases rises, the demand for nuclear imaging devices is expected to increase, propelling market expansion.

Technological innovations are playing a crucial role in enhancing the capabilities of nuclear imaging devices. Developments in imaging techniques, such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), are improving the accuracy and resolution of diagnostic images. These advancements enable healthcare professionals to detect diseases at earlier stages, leading to better patient outcomes. Additionally, the integration of artificial intelligence and machine learning in nuclear imaging is streamlining image analysis and interpretation, further enhancing the efficiency of diagnostic processes. As these technologies continue to evolve, the nuclear imaging devices market is likely to attract significant investments from healthcare providers and manufacturers.

Moreover, the increasing focus on personalized medicine and targeted therapies is influencing the growth of the nuclear imaging devices market. As healthcare shifts towards more individualized treatment approaches, the need for precise diagnostic tools becomes paramount. Nuclear imaging devices provide valuable insights into patient-specific conditions, allowing for tailored treatment plans. Furthermore, the growing emphasis on early detection and preventive healthcare is driving the adoption of nuclear imaging technologies. As the market evolves, the integration of nuclear imaging with other diagnostic modalities is expected to create new opportunities, further fueling growth in this dynamic sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• PET Devices
• SPECT Devices
• Planar Imaging Devices

By Application

• Oncology
• Cardiology
• Neurology
• Others (Nephrology, Immunology, etc.)

By End-User

• Hospitals
• Imaging Centers
• Academic And Research Centers
• Others (Clinics, CROs, Etc.)

COMPANIES PROFILED

• Koninklijke Philips NV, GE HealthCare Technologies Inc, Siemens Healthineers AG, Canon Medical Systems Corporation, Shimadzu Corporation, United Imaging Healthcare Co, MR Solutions, Cubresa Inc, Neusoft Medical Systems Co Ltd, Mediso Ltd, MIE GmbH, Others

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. PET Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. SPECT Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Planar Imaging Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others (Nephrology, Immunology, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic And Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others (Clinics, CROs, Etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NUCLEAR IMAGING DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Koninklijke Philips N.V
  • 9.2.2 GE HealthCare Technologies Inc
  • 9.2.3 Siemens Healthineers AG
  • 9.2.4 Canon Medical Systems Corporation
  • 9.2.5 Shimadzu Corporation
  • 9.2.6 United Imaging Healthcare Co
  • 9.2.7 MR Solutions
  • 9.2.8 Cubresa Inc
  • 9.2.9 Neusoft Medical Systems Co. Ltd
  • 9.2.10 Mediso Ltd
  • 9.2.11 MIE GmbH
  • 9.2.12 Others